Article
The Mitochondria-Targeted Methylglyoxal Sequestering Compound, MitoGamide, Is Cardioprotective in the Diabetic Heart.
Cardiovascular drugs and therapy - 1 Dec 2019
Tate Mitchel, Higgins Gavin C, De Blasio Miles J, Lindblom Runa, Prakoso Darnel, Deo Minh, Kiriazis Helen, Park Min, Baeza-Garza Carlos D, Caldwell Stuart T, Hartley Richard C, Krieg Thomas, Murphy Michael P, Coughlan Melinda T, Ritchie Rebecca H
Abstract excerpt
PURPOSE: Methylglyoxal, a by-product of glycolysis and a precursor in the formation of advanced glycation end-products, is significantly elevated in the diabetic myocardium. Therefore, we sought to investigate the mitochondria-targeted methylglyoxal scavenger, MitoGamide, in an experimental model of spontaneous diabetic cardiomyopathy. METHODS: Male 6-week-old Akita or wild type mice received daily oral gavage of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
